The Sun Initiative: Free CE on sun protection
May 15th 2012Eye care professionals now have easy access to important information for educating and prescribing sun protection. The AOA and Opticians Association of America (OAA), with support from Luxottica and The Vision Council, announced the launch of the first of three, free continuing education modules in support of the Sun Initiative.
In-office edging system is feature-rich, yet affordable
May 15th 2012Essilor Instruments announced the newest addition to its U.S. line of high-efficiency finishing products. Mr. Orange is a tracing, blocking, and edging system that features such integrated functions as management of high curves up to base 9 and optical tracing for fast rimless and groove jobs.
CooperVision sponsors Optometry Giving Sight, gets FDA OK for Avaira toric CLs
May 15th 2012The Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric 2-week silicone hydrogel contact lenses for astigmatism. The lenses are available for select distribution beginning this month.
New devices help fine tune age-related macular degeneration management
May 1st 2012Genetic testing, spectral-domain optical coherence tomography, multispectral digital ophthalmology, microperimetry using line-scanning laser ophthalmoscope, and preferential hyperacuity perimeter are among the newest technologies that are raising the standard of care for age-related macular degeneration.
Free form individualized lenses present opportunities, challenges
May 1st 2012The current system of eyeglass lens manufacturing, in which semi-finished "blanks" are delivered and finished in on-site laboratories, will give way to a system in which individually designed lenses are crafted for each patient.
Process key to pain management
May 1st 2012An optometrist's understanding of ocular pain management must always be evolving as you become more immersed in primary care, but, according to recent literature, most doctors under evaluate a patient's pain and discomfort and often don't prescribe enough medication.
Applying an evidence-based approach to macular disorders
May 1st 2012Currently there is a significant evidence-based shift toward anti-VEGF therapy as first-line treatment for diabetic macular edema, macular edema associated with vein occlusion, and active exudative age-related macular degeneration (AMD).